advertisement
Wong JC 14
Showing records 1 to 14 |
Display all abstracts from Wong JC104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma centerWong JC
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devicesStarr MR
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma centerWong JC
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devicesStarr MR
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma centerShiuey EJ
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devicesHuang D; Wong JC
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma centerRazeghinejad R
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devicesWong JC; Patel LG
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma centerShukla AG; Shukla AG; Kolomeyer NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devicesAmmar M
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma centerKolomeyer NN; Myers JS
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devicesHsu J; Sivalingam A
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma centerPro MJ; Lee D
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devicesMehta S; Ho AC; Kuriyan AE; Khan MA; Cohen MN; Xu D; Lee D; Moster MR; Yonekawa Y
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045